相似文献
1
A case of new onset Crohn's disease after renal transplantation.
Gastroenterol Hepatol (N Y). 2008 Dec;4(12):877-8.
2
[Secondary (AA) amyloidosis in Crohn's disease].
Acta Med Croatica. 2011;65(3):271-8.
3
Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases.
Aliment Pharmacol Ther. 2004 Oct 15;20(8):843-50. doi: 10.1111/j.1365-2036.2004.02197.x.
4
Course of Crohn's disease after allogeneic marrow transplantation.
Gastroenterology. 1998 Mar;114(3):433-40. doi: 10.1016/s0016-5085(98)70525-6.
5
Sex-specific risks for pediatric onset among patients with Crohn's disease.
Clin Gastroenterol Hepatol. 2003 Jul;1(4):303-9.
6
Familial cases of glomerulonephritis complicating Crohn's disease.
J Crohns Colitis. 2009 Jun;3(2):125-7. doi: 10.1016/j.crohns.2009.01.002. Epub 2009 Feb 4.
7
Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
J Ren Care. 2009 Sep;35(3):147-50. doi: 10.1111/j.1755-6686.2009.00106.x.
8
Stem cell transplantation as rescue therapy for refractory Crohn's disease: a sytematic review.
Tunis Med. 2014 Nov;92(11):655-9.
9
Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland.
Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1439-47. doi: 10.1097/00042737-200112000-00007.
10
Fulminant Crohn's colitis after allogeneic stem cell transplantation.
Gut. 2003 Oct;52(10):1518-21. doi: 10.1136/gut.52.10.1518.
引用本文的文献
1
An AI-assisted morphoproteomic approach is a supportive tool in esophagitis-related precision medicine.
EMBO Mol Med. 2025 Mar;17(3):441-468. doi: 10.1038/s44321-025-00194-7. Epub 2025 Feb 3.
2
Gastrointestinal complications after kidney transplantation.
World J Gastroenterol. 2020 Oct 14;26(38):5797-5811. doi: 10.3748/wjg.v26.i38.5797.
3
Clinical management of inflammatory bowel disease in the organ recipient.
World J Gastroenterol. 2014 Apr 7;20(13):3525-33. doi: 10.3748/wjg.v20.i13.3525.
4
Crohn's disease and solid organ transplantation.
Gastroenterol Hepatol (N Y). 2008 Dec;4(12):877-8.
本文引用的文献
1
De novo Crohn's disease in a renal transplant recipient.
Transplant Proc. 2007 May;39(4):1278-9. doi: 10.1016/j.transproceed.2007.03.045.
2
Crohn's-like changes in the colon due to mycophenolate?
Colorectal Dis. 2005 Jan;7(1):27-34. doi: 10.1111/j.1463-1318.2004.00695.x.
3
Mycophenolate mofetil in refractory inflammatory bowel disease.
Aliment Pharmacol Ther. 2003 Jun 1;17(11):1365-9. doi: 10.1046/j.1365-2036.2003.01581.x.
4
Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea.
Transplantation. 2003 Mar 15;75(5):665-72. doi: 10.1097/01.TP.0000053753.43268.F0.
5
Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.
Gut. 1999 May;44(5):625-8. doi: 10.1136/gut.44.5.625.
6
A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease.
Am J Gastroenterol. 1997 Feb;92(2):279-82.
7
Familial occurrence of inflammatory bowel disease.
N Engl J Med. 1991 Jan 10;324(2):84-8. doi: 10.1056/NEJM199101103240203.
Zotero 插件